Add this topic to your myFT Digest for news straight to your inbox
Takeda’s offer to pay $65bn for Shire comes amid a rush of M&A deals in healthcare
$2.6bn cost for taking a medicine from discovery to market remains stubbornly high
Pharma frenzy, lethal loneliness, beyond the bombs
Tackling NCDs, Jim O’Neill, bad news for night owls
South African-listed Netcare blames rising rents and decline in private and NHS work
Innovation award, nerve agents, happy Finns
Efforts to find a treatment or cure are intensifying as more drugs flunk trials. We also look at dementia’s growing financial burden, China’s big potential care market, and why some scientists are turning to Ayurvedic medicine
Dementia research is lagging far behind other health conditions such as HIV/Aids and cancer
Virtual reality simulator in Japan looks to end younger people’s indifference to sufferers
Countries such as China and Thailand have rising numbers of dementia patients
Higher health insurance premiums may be the only solution
Studies find that hearing loss is also associated with the disease
Herbs used in the ancient healing system could yield a cure
Philips’ Frans van Houten, tobacco tussles, food fights
Apps alert doctors to infections and help them keep an eye on the healing process
Revenues drop 5% as Middle East admissions fall in wake of lower oil prices
Authorities are investigating whether companies aggravated a shortage of the vital medical product to boost profits
Sheila Tlou on nursing, anti-vaxxers, dating with genetics
Recent moves by Beijing could open the door to wider coverage
Cheaper drugs cut burden on Sanming budget, but locals grumble over quality of care
Healthcare is where Big Tech is posing its largest challenge to the industry
Groups can disrupt the system by turning data records into something people value
Modicare, the hungry US tapeworm, record Unicef appeal
Taking cost out of the US health system means forcing hard choices
